One Health Group develops Voyce, a noncontact intelligent biometric sensor and patented mobile health assessment technology for remote animal health diagnostics. Voyce provides real-time monitoring of vitals and conditions including heart rate, heart function, blood pressure, pulmonary irregularities, tumor detection, cardiopulmonary monitoring and sleep apnea at clinically proven accuracies. The device is non-invasive and can be housed on a collar as a small unobtrusive unit; earlier versions have been used globally in clinics and major research facilities, amassing over a million hours of clinic time. One Health Group partners with academic institutions and medical-technology companies to advance its biometric monitoring platform. The company aims to integrate animal, human, and environmental data to improve diagnostics, monitoring, and preventive care. Voyce version 4, with substantial technological updates, is slated for release in 2023.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2021